CTai Anti-Viral Nasal Spray

Respiratory viruses are important pathogens that affect human health extensively, especially in autumn and winter, often causing cluster outbreaks。

Although vaccine products are still an important line of defense, the R&D challenges are huge, and it is difficult to catch up with the virus mutations.

Blocking the entry of viruses from the nose is an effective means of virus defense. The virus first infects the upper respiratory tract, including the nasal mucosa, and the nasal cavity is the first and most important passage of viral infection, so it is important to protect against nasal infection

➢ Development of effective nasal sprays that form a strong layer of protection in the nasal passages is a logical way to prevent the invasion of viruses.

CTai novel anti-viral nasal spray

• Easy to procure and distribute → sold over the counter, etc.

• Easy to use → just spray into each nostril

• Offer broad-spectrum protection against multiple viruses and their mutations

• Proven efficacy against Covid, Flu, RSV, Rhinovirus

• Non–invasive means of administration

• Easy to carry and use as needed

Two nasal spray formulations (HK1 and HK2) designed to inhibit respiratory infectious viruses, including:

• Respiratory syncytial virus (RSV)

• Covid (SARS-CoV-2)

• Influenza virus (IFV)

• Rhinovirus (HRV)

• Both formulations have shown significant antiviral effects (see Appendix for efficacy results)

• Both formulations are broad-spectrum, anti-respiratory virus products

• Contain only plant-based and naturally derived components

• Scientifically formulated and optimized through extensive experimentation

• To help prevent respiratory viruses, spray directly into nasal cavities 2-4 times daily